Healthcare - Biotechnology - NASDAQ - US
$ 0.8639
-3.72 %
$ 59.3 M
Market Cap
-0.53
P/E
BALANCE SHEET
198 M
ASSETS
47.4 M
LIABILITIES
151 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Vor Biopharma Inc.
| Current Assets | 141 M |
| Cash & Short-Term Investments | 137 M |
| Receivables | 0 |
| Other Current Assets | 3.63 M |
| Non-Current Assets | 57.3 M |
| Long-Term Investments | 0 |
| PP&E | 50.1 M |
| Other Non-Current Assets | 7.22 M |
| Current Liabilities | 15.6 M |
| Accounts Payable | 815 K |
| Short-Term Debt | 7.66 M |
| Other Current Liabilities | 7.1 M |
| Non-Current Liabilities | 31.8 M |
| Long-Term Debt | 63.7 M |
| Other Non-Current Liabilities | -31.8 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 31.4 | 57.7 | 119.8 | 48.5 | 6.5 | 0.9 |
| Short Term Investments | 105.8 | 172.5 | 87.7 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 6.8 | 6.7 | 6.9 | 0.6 | 1.1 | 7 K |
| Total Current Assets | 140.8 | 236.9 | 214.4 | 49.1 | 7.5 | 0.9 |
| PP&E | 50.1 | 57.1 | 22.5 | 21.8 | 0.7 | 71 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 2.4 | 2.4 | 1.6 | 1.6 | 0 |
| Other Long Term Assets | 7.2 | 2.9 | 3.3 | 3.4 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 198.1 | 299.4 | 242.6 | 75.9 | 9.8 | 1.0 |
| LIABILITIES | ||||||
| Accounts Payable | 0.8 | 1.8 | 1.5 | 2.4 | 0.7 | 38 K |
| Short Term Debt | 7.7 | 6.5 | 3.7 | 1.7 | 0 | 4.5 |
| Other Current Liabilities | 7.1 | 4.8 | 4.9 | 6.1 | 1.5 | 3.3 |
| Total Current Liabilities | 15.6 | 13.1 | 10.2 | 10.2 | 2.2 | 7.8 |
| Long Term Debt | 63.7 | 71.3 | 32.3 | 34.9 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | (31.8) | (35.6) | (16.2) | (17.4) | 0 | 0 |
| Total Liabilities | 47.4 | 48.8 | 26.3 | 27.6 | 2.2 | 7.8 |
| EQUITY | ||||||
| Common Stock | 7 K | 7 K | 4 K | 1 K | 0 | 0 |
| Retained Earnings | (340.1) | (222.2) | (130.1) | (61.2) | (17.9) | (7.0) |
| Other Accumulative Comprehensive Income/Loss | 77 K | (0.8) | (242.6) | 0 | 0 | 0 |
| Total Equity | 150.7 | 250.6 | 216.3 | 48.3 | 7.6 | (6.8) |
| Total Liabilities and Equity | 198.1 | 299.4 | 242.6 | 75.9 | 9.8 | 1.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 67.2 | 39.6 | 37.2 | 37.1 | 37.1 | 5.7 |